Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 3/20 | 0.53 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.53 |
| ▸ | PARP1 | P09874 | 6/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.44 |
| ▸ | SMYD3 | Q9H7B4 | 3/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | CECR2 | Q9BXF3 | 1/20 | 0.38 |
| ▸ | PTPRC | P08575 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7711118 | 0.84 | KCNH2 (0.40) | PDE3BPDE3APARP1KDRKCNH2 | |
| SCHEMBL7001705 | 0.80 | PARP1 (0.64) | PDE3BPDE3APARP1KDRSMYD3 | |
| SCHEMBL7000241 | 0.77 | PARP1 (0.52) | PDE3BPDE3APARP1KDRSMYD3 | |
| SCHEMBL6997046 | 0.75 | PARP1 (0.71) | PDE3BPDE3APARP1KDRSMYD3 | |
| SCHEMBL26000858 | 0.75 | PDE3B (0.55) | PDE3BPDE3APARP1KDRSMYD3 | |
| SCHEMBL531868 | 0.75 | SMYD3 (0.57) | PDE3BPDE3APARP1KDRSMYD3 | |
| SCHEMBL6997052 | 0.74 | PARP1 (0.43) | PDE3BPDE3APARP1KDRSMYD3 | |
| SCHEMBL6997050 | 0.74 | PARP1 (0.51) | PDE3BPDE3APARP1KDRSMYD3 | |
| SCHEMBL6992569 | 0.74 | PDE3B (0.54) | PDE3BPDE3APARP1KDR | |
| SCHEMBL5670717 | 0.73 | PARP1 (0.62) | PDE3BPDE3APARP1SMYD3BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1015437-B1 | BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS | SCHERING AG (DE) | 2003-12-03 | — | — | EP | disclosed |
| US-6365736-B1 | TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-04-02 | — | — | US | disclosed |